These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1631808)

  • 21. Clinical use of thrombolytic agents in venous thromboembolism.
    Sasahara AA; Sharma GV; Tow DE; McIntyre KM; Parisi AF; Cella G
    Arch Intern Med; 1982 Apr; 142(4):684-8. PubMed ID: 7073411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma fibrinolysis and postoperative deep vein thrombosis.
    Macintyre IM; Webber RG; Crispin JR; Jones DR; Wood JK; Allan NC; Prescott RJ; Ruckley CV
    Br J Surg; 1976 Sep; 63(9):694-7. PubMed ID: 963414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombolytic and pharmacokinetic properties of a recombinant chimeric plasminogen activator consisting of a fibrin fragment D-dimer specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Dewerchin M; Vandamme AM; Holvoet P; De Cock F; Lemmens G; Lijnen HR; Stassen JM; Collen D
    Thromb Haemost; 1992 Aug; 68(2):170-9. PubMed ID: 1412163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pulmonary embolism and deep vein thrombosis with thrombolytic therapy.
    Volgesang GB; Bell WR
    Clin Chest Med; 1984 Sep; 5(3):487-94. PubMed ID: 6386293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical comparison of intermittent streptokinase and intermittent streptokinase plasminogen therapy.
    Barlow GH; Kakkar VV; Bentley PG; Chan PS; Jones NA; Mistry FD
    Thromb Res; 1979; 15(1-2):135-42. PubMed ID: 483271
    [No Abstract]   [Full Text] [Related]  

  • 26. [Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters].
    Marchena Yglesias PJ; Nieto Rodríguez JA; Serrano Martínez S; Belinchón Moya O; Cortés Carmona A; Díaz de Tuesta A; Bruscas Alijarde MJ; Ruiz Ribó MD
    An Med Interna; 2006 Mar; 23(3):105-10. PubMed ID: 16737429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of pulmonary embolism].
    Mühl D
    Orv Hetil; 2008 May; 149(20):935-48. PubMed ID: 18467263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism and gynecologic surgery.
    Bonnar J
    Clin Obstet Gynecol; 1985 Jun; 28(2):432-46. PubMed ID: 2410173
    [No Abstract]   [Full Text] [Related]  

  • 29. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 30. Reliable rapid blood test for the exclusion of venous thromboembolism in symptomatic outpatients.
    Turkstra F; van Beek EJ; ten Cate JW; Büller HR
    Thromb Haemost; 1996 Jul; 76(1):9-11. PubMed ID: 8819243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolytic therapy: Current status.
    Fratantoni JC; Ness P; Simon TL
    N Engl J Med; 1975 Nov; 293(21):1073-8. PubMed ID: 1178024
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
    Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
    Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the combination of a bedside D-dimer assay and enzyme-linked immunosorbent soluble fibrin assay in patients with suspected venous thromboembolism.
    Brimble KS; Ginsberg JS
    Thromb Res; 1997 Nov; 88(3):291-7. PubMed ID: 9526949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombolytic therapy with streptokinase.
    Chesterman CN; Biggs JC
    Med J Aust; 1970 Oct; 2(18):839-46. PubMed ID: 4923084
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolytic therapy. For pulmonary embolism and deep venous thrombosis.
    Fowler AA; Hyers TM
    Postgrad Med; 1982 Apr; 71(4):149-54, 158. PubMed ID: 7071026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombolytic therapy in treatment: summary of an NIH Consensus Conference.
    Br Med J; 1980 Jun; 280(6231):1585-7. PubMed ID: 7000246
    [No Abstract]   [Full Text] [Related]  

  • 37. Thrombolytic therapy.
    Kakkar VV; Scully MF
    Br Med Bull; 1978 May; 34(2):191-9. PubMed ID: 148935
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective assessment of the natural history of positive D-dimer results in persons with acute venous thromboembolism (DVT or PE).
    Kuruvilla J; Wells PS; Morrow B; MacKinnon K; Keeney M; Kovacs MJ
    Thromb Haemost; 2003 Feb; 89(2):284-7. PubMed ID: 12574808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Streptokinase and urokinase.
    Med Lett Drugs Ther; 1978 Apr; 20(8):37-8. PubMed ID: 634226
    [No Abstract]   [Full Text] [Related]  

  • 40. [Increased fibrinolytic activity by sequential treatment with defibrase-plasminogen-urokinase in pulmonary embolism and deep venous thrombosis].
    Brochier M; Griguer P; Raynaud P; Fauchier JP; Charbonnier B
    Arch Mal Coeur Vaiss; 1981 Jul; 74(7):761-9. PubMed ID: 6794497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.